Senexin A is an inhibitor of CDK8/19 (IC50: 280 nM, CDK8) and an inhibitor downstream of p21 transcription. It only inhibits p21-induced transcription but does not inhibit other biological effects of p21. Senexin A inhibits CMV-GFP induction as well as the p21 stimulatory activity of the consensus NF-kappaB-dependent promoters[1][2].
Molecular Weight:
274.32
Purity:
99.79
CAS Number:
[1366002-50-7]
Formula:
C17H14N4
Target:
CDK
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted